PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.6422
+0.0104 (1.65%)
Jun 9, 2025, 4:00 PM - Market closed
PAVmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1.99 | 3 | 2.45 | 0.38 | 0.5 | - | Upgrade
|
| Revenue Growth (YoY) | -33.92% | 22.14% | 550.40% | -24.60% | - | - | Upgrade
|
| Cost of Revenue | 3.13 | 4.84 | 6.42 | 3.61 | 0.59 | - | Upgrade
|
| Gross Profit | -1.14 | -1.85 | -3.97 | -3.24 | -0.09 | - | Upgrade
|
| Selling, General & Admin | 29.79 | 36.15 | 48.53 | 60.73 | 34.32 | 12.39 | Upgrade
|
| Research & Development | 4.78 | 5.93 | 14.28 | 25.34 | 19.85 | 10.96 | Upgrade
|
| Operating Expenses | 34.76 | 42.64 | 64.83 | 87.85 | 54.31 | 23.35 | Upgrade
|
| Operating Income | -35.9 | -44.49 | -68.8 | -91.09 | -54.39 | -23.35 | Upgrade
|
| Interest Expense | -0.03 | -0.05 | -0.59 | -1.28 | - | -0.05 | Upgrade
|
| Interest & Investment Income | 0.19 | 0.25 | 0.51 | 0.17 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 7.59 | 4.42 | -7.6 | -4.33 | 1.68 | -5.99 | Upgrade
|
| EBT Excluding Unusual Items | -28.15 | -39.86 | -76.48 | -96.53 | -52.71 | -29.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | 21.54 | 0.53 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 72.29 | 72.29 | 1 | - | - | - | Upgrade
|
| Other Unusual Items | -0.11 | -4.54 | -3.78 | -6.71 | -3.42 | -6.5 | Upgrade
|
| Pretax Income | 65.56 | 28.43 | -79.26 | -103.24 | -56.13 | -35.89 | Upgrade
|
| Earnings From Continuing Operations | 65.56 | 28.43 | -79.26 | -103.24 | -56.13 | -35.89 | Upgrade
|
| Minority Interest in Earnings | 8.41 | 11.36 | 15.09 | 14.26 | 5.78 | 1.61 | Upgrade
|
| Net Income | 73.97 | 39.79 | -64.18 | -88.98 | -50.35 | -34.28 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.52 | 7.83 | 2.1 | 0.28 | 0.28 | 0.29 | Upgrade
|
| Net Income to Common | 72.45 | 31.97 | -66.27 | -89.26 | -50.63 | -34.56 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 10 | 7 | 6 | 5 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 65 | 7 | 6 | 5 | 3 | Upgrade
|
| Shares Change (YoY) | 879.09% | 802.87% | 21.78% | 14.91% | 63.42% | 57.07% | Upgrade
|
| EPS (Basic) | 6.61 | 3.30 | -9.16 | -15.03 | -9.80 | -10.93 | Upgrade
|
| EPS (Diluted) | 0.96 | 0.50 | -9.16 | -15.03 | -9.80 | -10.93 | Upgrade
|
| Free Cash Flow | -22.05 | -33.61 | -52.28 | -72.53 | -42.06 | -21.97 | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -0.52 | -7.23 | -12.21 | -8.14 | -6.95 | Upgrade
|
| Gross Margin | -57.15% | -61.60% | -161.83% | - | -17.00% | - | Upgrade
|
| Operating Margin | -1801.15% | -1485.38% | -2805.67% | -24161.01% | -10878.60% | - | Upgrade
|
| Profit Margin | 3635.17% | 1067.31% | -2702.69% | -23677.45% | -10126.00% | - | Upgrade
|
| Free Cash Flow Margin | -1106.12% | -1122.17% | -2132.06% | -19237.40% | -8412.00% | - | Upgrade
|
| EBITDA | -35.24 | -43.29 | -65.86 | -88.63 | -54.17 | -23.33 | Upgrade
|
| D&A For EBITDA | 0.66 | 1.2 | 2.93 | 2.46 | 0.23 | 0.02 | Upgrade
|
| EBIT | -35.9 | -44.49 | -68.8 | -91.09 | -54.39 | -23.35 | Upgrade
|
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.